Status:

TERMINATED

A 52-Week Study to Assess the Effects of MK0822 on Knee Osteoarthritis (MK-0822-011)

Lead Sponsor:

Merck Sharp & Dohme LLC

Conditions:

Osteoarthritis

Eligibility:

All Genders

40+ years

Phase:

PHASE2

Brief Summary

The purpose of this study is to test MK0822 on disease activity in patients with osteoarthritis in the knee. Disease modifying activity of MK0822 will be assessed by measurements of knee cartilage usi...

Eligibility Criteria

Inclusion

  • Patients with symptomatic knee osteoarthritis for at least 6 months based on clinical and radiographic criteria
  • Patients should be in general good health and must have a certain level of knee pain or be taking pain medicines on most days
  • Specific radiographic (X-ray) and MRI features must also be satisfied

Exclusion

  • Non-osteoarthritic causes of knee pain
  • Ineligibility to undergo MRI of the knee due to patient tolerability or safety reasons
  • Previous septic arthritis, tibial osteotomy or knee replacement in both knees
  • Acute injury of knee ligaments or meniscus in past 2 years
  • Knee arthroscopy in past 12 months
  • Anticipated arthroscopy or surgery in next 18 months
  • Use of intra-articular injections of hyaluronan (e.g. Hyalgan (TM), Synvisc (TM), Orthovisc (TM)) in past 6 months, or injections of glucocorticoids (e.g. Kenalog (TM), Aristospan (TM), Depo-Medrol (TM)) in past 3 months or anticipated knee injections during the study
  • Glucosamine or chondroitin sulfate are allowable if they are at a stable dose for past 3 months and will continue at that dose during the study
  • Other exclusion criteria apply-Please ask the study doctor for details

Key Trial Info

Start Date :

October 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2007

Estimated Enrollment :

2 Patients enrolled

Trial Details

Trial ID

NCT00397683

Start Date

October 1 2006

End Date

April 1 2007

Last Update

November 2 2015

Active Locations (16)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (16 locations)

1

Call for Information

Palm Desert, California, United States, 92260

2

Call for Information

Pomona, California, United States, 91767

3

Call for Information

Torrance, California, United States, 90505

4

Call for Information

Upland, California, United States, 91786